tradingkey.logo
tradingkey.logo
Pesquisar

QuidelOrtho Corp

QDEL
Adicionar à lista de desejos
18.250USD
+0.070+0.39%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
1.24BValor de mercado
PerdaP/L TTM

Mais detalhes de QuidelOrtho Corp Empresa

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.

Informações de QuidelOrtho Corp

Código da empresaQDEL
Nome da EmpresaQuidelOrtho Corp
Data de listagemFeb 01, 1991
CEOBlaser (Brian J)
Número de funcionários6600
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 01
Endereço9975 Summers Ridge Road
CidadeSAN DIEGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92121
Telefone18585521100
Sitehttps://www.quidelortho.com/
Código da empresaQDEL
Data de listagemFeb 01, 1991
CEOBlaser (Brian J)

Executivos da empresa QuidelOrtho Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
89.38K
+7.64%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
+13.88%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
55.11K
+14.77%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
43.18K
+4.96%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
29.43K
+4.25%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
23.26K
+35.41%
Mr. John R. Chiminski
Mr. John R. Chiminski
Independent Director
Independent Director
9.35K
+73.02%
Dr. Mary Lake Polan, M.D., Ph.D.
Dr. Mary Lake Polan, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Kenneth Jon (Ken) Widder, M.D.
Dr. Kenneth Jon (Ken) Widder, M.D.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
113.39K
+1.90%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
89.38K
+7.64%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
75.72K
+13.88%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
55.11K
+14.77%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
43.18K
+4.96%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
29.43K
+4.25%

Perguntas frequentes

Quem são os cinco principais acionistas de QuidelOrtho Corp?

Os cinco principais acionistas de QuidelOrtho Corp são: Dr. Kenneth F. Buechler, Ph.D.

Quantas instituições possuem ações da QuidelOrtho Corp (QDEL)?

Em 2026Q1, 619 instituições possuíam ações da QuidelOrtho Corp, com valor de mercado aproximado de 88.33M, representando 129.53% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -14180850.00.

Qual é a maior fonte de receita da QuidelOrtho Corp?

Em 2026Q1, o segmento de negócios Labs gerou a maior receita para QuidelOrtho Corp, totalizando 373.80M e representando 53.41% da receita total.